12 July 2021
Dr Mairi Gibbs, formerly Head of Operations at Oxford University Innovation (OUI), has been promoted to Chief Operating Officer at OUI, taking the reins from the outgoing Dr Adam Stoten.
18 May 2021
This is a new post, which will work in support of the priorities in the University Strategic Plan 2018-2023 and the Knowledge Exchange Strategy, around innovation and entrepreneurship.
Oxford University and Prenetics announce landmark collaboration to scale rapid testing tech globally
20 April 2021
Today, the University of Oxford, Prenetics Limited, a global leader in diagnostics and genetic testing, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop the award-winning OxLAMP technology, a rapid, molecular testing technology for infectious diseases.
10 February 2021
The World’s First Conservation Venture Studio has today been launched, with a mission to bring forward novel and innovative solutions to the world’s most pressing environmental problems.
23 November 2020
OxVent is a rapidly deployable and scalable low-cost mechanical ventilator specially designed for COVID-19, which has now been recognised as one of the best innovations of the year by the Institute of Engineering and Technology.
18 March 2020
Scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre for Advanced Research (OSCAR) have developed a rapid testing technology for the novel corona virus SARS-CoV-2 (COVID-19). The team, led by Prof. Zhanfeng Cui and Prof. Wei Huang, have been working to improve test capabilities as the virus spreads internationally.
4 March 2019
Oxford Sciences Innovation Plc (OSI) has announced two new Board-level appointments, with experienced technology entrepreneur Charles Conn joining as Chief Executive and former Google CFO Patrick Pichette joining as Chairman.
13 March 2018
OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.
20 October 2017
In stopping disease, early diagnosis is key, but hampered by expensive and time consuming blood tests. But what if we could diagnose disease as easily as we can measure glucose levels? Article by Gregg Bayes-Brown, Marketing and Communications Manager, Oxford University Innovation.